[20]	2002	Hospitalized patients’ urine, high vaginal swabs, blood, wound and abscess swabs, had culture obtained	39	18 (46)	No genotypic characterization reported.
[20]	2002	Outpatients’ urine, high vaginal swabs, blood, wound and abscess swabs, had culture obtained	41	0 (0)	No genotypic characterization reported.
[23]	Study period not reported	Hospitalized patients’ skin and soft tissue had culture obtained	102	56 (55)	Data from SCCmec typing study not reported. 35 virulence-associated genes examined.
[24]	2007-2008	Outpatients’ skin and soft tissue, ear, conjunctiva, and urinary tract samples had cultures obtained (Dominican Republic)	112	22 (20%)	MRSA SCCmec IV (82%) MRSA PVL+ (45%) MRSA SCCmec V (18%) Spa-CC665/ST30 PVL+ (27%) Spa-CC148/ST72 (23%) Spa-CC002/ST5 (18%) MSSA (80%) MSSA PVL+ (46%) Spa-CC665/ST30 PVL+ (33%) Spa-CC002/ST5 (7.8%) Spa-CC002/t571/ST398 (7.8%) t008 USA300 MSSA (3.3%) Spa-CC008/ST8 (6.6%) MRSA MRSA PVL+ (8.9%) ST8 spa t304 SCCmec IVc PVL− (49%) spa-CC0044/ST80 (13%) spa-CC002/ST5 (18%) spa-CC008 t008 USA300 (12.5%) MSSA (61%) MSSA PVL+ (10.3%) spa-CC1096/ST152 (15%) spa-CC571/ST398 (10%)
[24]	2007-2008	Outpatients’ skin and soft tissue, blood, lung, and urinary tract samples had cultures obtained (Martinique)	143	56 (39%)
[25]	2014	Hospitalized patients’ post-surgery wound sites had culture obtained	Data not reported	4	No genotypic characterization data reported.
[27]	2011-2012	Hospitalized patients’ wounds, sputum, urine and catheter tip, ear and nasal swabs, and knee aspirate had culture obtained	Data not reported	61	SCCmec typing confirmed in only 34 isolates. SCCmec type IV (85%) SCCmec type II (9%) SCCmec type III (3%) SCCmec type I (3%)